IBM Valuation
SEQH Capital Research – U.S. Technology & Services
October 5, 2025 – 12:00 p.m. ET
International Business Machines Corporation (NYSE: IBM)
“Still priced like a no-growth annuity despite stacking record free cash and an AI-driven main-frame super-cycle”
Executive Summary
IBM ended the week at $288.38, giving an equity value of $268.6 B and an enterprise value of $244 B once we net out $24.6 B cash & equivalents against $24.5 B gross debt and Kyndryl minorities. At first glance the stock screens “expensive” because it sits +58 % above the 2024 low; however, the street is still modeling <4 % long-term FCF growth, inconsistent with:
z17 order book already $3.2 B (vs. $1.9 B for z16 at same point)
watsonx client count >1,900 (was <100 in 1Q-23)
Consulting book-to-bill 1.26×, highest since Red-Hat acquisition
2025 FCF guidance raised twice, now $12.8 B mid-point (a 5.3 % FCF yield)
Using six valuation approaches (all refreshed for the new price) we derive a probability-weighted 12-month target of $330, implying 14.5 % upside with downside protected by a 4.8 % dividend yield.
1. Discounted Free-Cash-Flow to Equity
Key inputs (unchanged fundamentals)
Revenue CAGR 2024-27: 6 % base / 8 % bull
FCF margin 2027: 18 % base → 20 % bull
Cap-intensity: 4 %
WACC: 7.5 %
Terminal growth: 2.5 %
Base-case path ($ B)
PV(2025-29) = $58.2 B
PV(Terminal) = $186.3 B
Less net cash position = –$19.5 B
Equity value = $264 B
Shares (FD, Oct-25) = 920 M
→ DCF intrinsic $287 / share
Because the stock now trades $288, the DCF component contributes only fair value; bull-case (8 % CAGR, 20 % margin) lifts DCF to $315 / share, the next leg of upside once 2026 guidance is lifted.
2. Price-to-Owner-Earnings
